Shruthi Ravimohan

Critic
DISC Type : C

Translational Strategy Leader Senior Scientific Director at Daiichi Sankyo US

United States

Overview

Shruthi is a highly motivated Translational Strategy Leader at Daiichi Sankyo, with extensive experience in ADCs, IO, small molecules, and biologics. She previously led translational teams at Bristol Myers Squibb on multiple assets, showcasing robust skills in cross-functional leadership.

Outside of her professional life, Shruthi has a keen interest in the groundbreaking discoveries in mRNA vaccine technology, especially the work of Drew Weissman and Katalin Kariko, having been a former postdoc in Drews lab.

Shruthi holds a PhD in Human Genetics from The Johns Hopkins University School of Medicine.

Personality Overview

Precise

Negotiator

Information Seeker

It is very likely that they will negotiate pricing or other important terms.  Unless the value is proven by data, they are unlikely to value fancy features. They prefer to analyze logically and value objective facts over emotions.

Topics They Care About

Translational Medicine Strategy
Currently driving Translational Strategy for a late-stage ADC asset at Daiichi Sankyo, demonstrating her expertise in designing and executing such strategies.
Biomarker Development
Her previous roles at Bristol Myers Squibb frequently listed "Biomarker Development" as a key skill, indicating a strong interest in this area.
Oncology Drug Development
With over 15 years of experience in oncology, her focus on ADCs, IO, and small molecules highlights her deep involvement in developing cancer therapies.

Media Appearances

Shruthi has no verified media appearances

Work History

2-2026
Translational Strategy Leader Senior Scientific Director at Daiichi Sankyo US
5-2024
Scientific Senior Director at Bristol Myers Squibb
5-2022 - 5-2024
Scientific Director, Oncology Translational Medicine Team Lead at Bristol Myers Squibb
1-2021 - 5-2022
Scientific Associate Director- Oncology Translational Medicine Team Lead at Bristol Myers Squibb
10-2019 - 1-2021
Oncology Clinical Biomarker Lead at Bristol Myers Squibb

Education

2004 - 2009
Doctor of Philosophy (PhD) from The Johns Hopkins University School of Medicine
2016 - 2018
Masters from University of Pennsylvania School of Medicine

More Information

Social Presence :

Prographics :

Exp : 22 Location : United States Job Level : Senior Designation : Translational Strategy Leader Senior Scientific Director at Daiichi Sankyo US
URL has been copied!

Insights For Selling To Shruthi

During A Call Or A Meeting

DO's

  • Be ready to answer many clarity-seeking questions and requests for information
  • If you can, show them industry reports or analyst comments instead of sharing anecdotal stories
  • Don’t forget to mention how you compare to competition on both features and pricing

DONT's

  • Avoid pushing them too much to involve other stakeholders unless it is critical
  • Don't give superficial answers, they are easily rattled by them
  • Avoid phrases like ‘trust me’, ‘others just love’ etc.

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Shruthi is

  • Proof of ROI, low pricing and objective proof points are the important factors for them.
  • Will you ever get a clear answer from Shruthi

  • They do not mind saying no if they believe that it is the right decision.

Insights For Deal Planning

    How fast (or slow) will Shruthi move?

  • Their decision-making is neither very fast nor very slow, they are somewhere in between.
  • Can Shruthi take some risk or not?

  • They can take risks if their analysis shows that it would be worth it.

You And Shruthi

Personality Compatibility


Other Daiichi Sankyo US Employees

Explore more public profiles from related professionals at the same organization.

More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.